Giacobini MaiBritt, Zhao Jingcheng, Freilich Jonatan, Malmgren Carolina, Wallin Bernhardsson Niklas, Ahnemark Ewa
PRIMA Järva, Stockholm, Sweden.
Karolinska Institutet, Stockholm, Sweden.
J Atten Disord. 2025 Feb;29(4):235-243. doi: 10.1177/10870547241303259. Epub 2024 Dec 25.
To evaluate care transition and medication use in young adults with ADHD in Sweden.
Observational retrospective study of patients with ADHD from the Swedish National Patient Register, Prescribed Drug Register, and Cause of Death Register (2018-2020). Last contact with pediatric psychiatric care, first contact with adult psychiatric care, and medication use were described for ages 18 to 21 years, inclusive.
Of 19,233 patients who had dispensed ADHD treatment, 85.8% had received adult psychiatric care by 21 years of age. The proportion of patients on medication was highest at age 18 years (80.1%), decreasing to 36.1% by age 21 years. By 21 years, there were significantly more patients on versus off ADHD medication who had received healthcare for autism, been prescribed selective serotonin re-uptake inhibitors, and received adult psychiatric outpatient visits (all < .0001).
This study demonstrates declining ADHD medication use during the pediatric-to-adult care transition for patients in Sweden.
评估瑞典患有注意力缺陷多动障碍（ADHD）的年轻人的护理过渡和药物使用情况。
对来自瑞典国家患者登记册、处方药登记册和死亡原因登记册（2018 - 2020年）的ADHD患者进行观察性回顾性研究。描述了年龄在18至21岁（含）之间的患者与儿科精神科护理的最后一次接触、与成人精神科护理的首次接触以及药物使用情况。
在19233名接受过ADHD治疗的患者中，85.8%在21岁时接受过成人精神科护理。18岁时使用药物的患者比例最高（80.1%），到21岁时降至36.1%。到21岁时，接受过自闭症医疗护理、被开了选择性5 - 羟色胺再摄取抑制剂以及接受过成人精神科门诊治疗的正在使用与未使用ADHD药物的患者之间存在显著差异（均P ＜.0001）。
本研究表明瑞典患者在从儿科护理向成人护理过渡期间，ADHD药物的使用呈下降趋势。
